How to Read a Peptide Certificate of Analysis

A peptide certificate of analysis (CoA) is a batch-specific analytical record stating which tests a manufacturer or contract laboratory ran on one defined lot of material, under what instrument conditions, and what numerical results those tests returned.

A CoA records measurements. It is not a warranty of performance, not a safety assessment, and not a statement about permitted applications. Its value as evidence rests on two things: whether it is traceable to the vial it accompanies, and whether it discloses enough method detail for an independent analyst to repeat the measurement.

Traceability is checked before any number is read

A CoA describes one lot. Lots are not interchangeable, because the impurity profile of a solid-phase synthesis depends on the coupling and deprotection efficiency of that particular run. A document with no lot identifier, or one that does not match the vial label, is not evidence about the vial.

The minimum traceability fields are the product name and full sequence, the lot number, the manufacture and analysis dates, and the laboratory that performed the testing, named separately from the manufacturer where testing was contracted out. Third-party results are discussed under lab testing.

Field by field

Purity and content are different quantities

The most frequent misreading is treating chromatographic purity as though it described the powder. Purity by reversed-phase HPLC is a ratio of ultraviolet peak areas: the target peak divided by the total integrated area of all detected peaks. It characterises the ultraviolet-absorbing material and nothing else; water, inorganic salts and the counterion are transparent at the usual detection wavelengths and never enter the calculation.

Net peptide content, sometimes labelled assay or peptide loading, is the separate figure for what fraction of the weighed powder is peptide, and the two can diverge substantially. Melanson et al. (2018) assigned purity to a candidate certified reference material for angiotensin II at the National Research Council of Canada by combining quantitative NMR, isotope-dilution LC-MS/MS amino acid analysis after hydrolysis, and mass balance. The trifluoroacetic acid counterion, measured by a validated fluorine-19 qNMR method, accounted for nearly 25% of the mass, and the final assigned value was 691 ± 9 mg/g (k = 2) — something a chromatographic purity figure alone would not have disclosed.

How that figure is arrived at varies. Li et al. (2019) reported a United States Pharmacopeia multi-laboratory study in which oxytocin content was determined by HPLC assay, quantitative NMR and amino acid analysis, the HPLC assay against the same bulk material showing the lowest inter-laboratory variability. McCarthy et al. (2023) set out a two-step assignment in which mass balance fixes a value for bulk material that then serves as the standard for the vialed material, noting that chiral or isobaric amino acids can require additional techniques before a peptide is fully characterised.

Laboratory calculations that begin from a weighed mass depend on the peptide fraction, not the gross powder mass, which is why net peptide content is the governing figure. Related material sits at the peptide calculator and in the notes on reconstitution.

The impurity classes a synthesis CoA is describing

D'Hondt et al. (2014) published a structured review of peptide-related impurities in the Journal of Pharmaceutical and Biomedical Analysis, separating those generated by solid-phase synthesis from those generated by later degradation. The synthesis classes include deletion sequences attributed to inefficient Fmoc-deprotection, insertion sequences attributed to excess amino acid reagent, diastereomers from racemization, protection adducts from incomplete side-chain deprotection, side-chain oxidation, and dimeric to oligomeric species; the degradation classes include beta-elimination, diketopiperazine, pyroglutamate and succinimide formation. The authors also record unwanted counter ions such as trifluoroacetate and contamination by unrelated peptides where good manufacturing practice was absent, noting that such impurities can influence early functionality studies and lead to erroneous conclusions.

A purity number is a one-line summary of that taxonomy. A CoA reporting 98% without a chromatogram gives no way to tell whether the other 2% is one deletion sequence or a dozen unresolved species.

Counterion entries

Peptides purified by reversed-phase HPLC are usually isolated as trifluoroacetate salts, since trifluoroacetic acid is the conventional ion-pairing additive. Cornish et al. (1999) reported, in vitro, that trifluoroacetate at 10⁻⁸ to 10⁻⁷ M reduced cell numbers and thymidine incorporation in fetal rat osteoblast cultures at 24 hours, with comparable observations in articular chondrocytes and neonatal mouse calvariae, and that trifluoroacetate salts of amylin, amylin-(1-8) and calcitonin gave consistently lower proliferation than the hydrochloride salts. That is a rodent cell-culture finding, cited only to explain why the counterion is treated as a reportable impurity with a measured mass contribution rather than an inert bystander.

What independent checking of supplier CoAs has found

Verbeke et al. (2015), at the Drug Quality and Registration group of Ghent University, evaluated commercially obtained synthetic quorum sensing peptides ordered at a requested purity of at least 95.0%. Using an in-house quality control flowchart, the authors reported a large discrepancy between the purity stated on suppliers' certificates of analysis and their own results, with 44.0% of the peptides meeting the requested purity. The main compound in one sample had a structure different from the peptide ordered, and most related impurities were sequences lacking one or more amino acids. The authors concluded that relying on supplier certificates alone may carry serious consequences for peptide research.

Gaps that make a CoA unevaluable

• No lot number, or one absent from the vial label.
• A purity percentage with no named method, wavelength, column or gradient.
• A transcribed number with no chromatogram or spectrum reproduced.
• Mass spectrometry summarised as "conforms" instead of theoretical and observed masses.
• No content, water or counterion entry, leaving the mass balance unaccounted for.
• Identical dates, traces or values recurring across different lots.
• No named analysing laboratory, signature or release date.

Regulatory status

A certificate of analysis is a manufacturing quality document. It confers no regulatory approval and does not indicate that a material has been reviewed by any agency. Vergote et al. (2009) observed that pharmacopoeial peptide specifications are barely harmonised, with large differences between the European Pharmacopoeia and the United States Pharmacopeia, so the acceptance criteria a laboratory applied belong alongside the numbers it reports. Materials described here are not approved by the FDA, are supplied for laboratory research use only, and are not for human or animal consumption; see the research use policy.

Frequently asked questions

Is a stated purity comparable between two suppliers?

Not directly. A purity figure is a measurement made under one set of chromatographic conditions. Two laboratories analysing the same lot with different columns, gradient slopes or detection wavelengths can report different values, because a shallow gradient resolves impurities that a steep one hides inside the main peak. Comparison means little unless the method conditions are compared alongside the percentages.

Should every lot have its own certificate?

Yes. The analysis is lot-specific, so a certificate reused across lots describes material that was never tested. A supplier should be able to produce the document for the exact lot printed on the vial.

What storage information belongs on a certificate?

The storage temperature for the lyophilized material, any requirement for protection from light and moisture, the container closure type, and a retest date. Analytical results describe the material as it stood on the analysis date under those conditions; handling is covered at peptide storage.

Can a certificate be verified independently?

Yes, by submitting a sample of the same lot to an independent laboratory and comparing both the values and the method conditions. A retest reproduces a measurement, not a judgement, so the second laboratory's acceptance criteria and instrument conditions belong with its results. Further detail is under lab testing.